Delivery Order SPE2DB20D2014-SPE2DB24FD16Q
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,811.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 25, 2024 and was awarded on June 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $4,131.24 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. The contract is not set aside for any specific business type....
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,372.16 and is a Firm Fixed Price delivery order with a completion date of January 13, 2025. The contract is not set aside for any specific small business program....
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $18,540.74, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,025.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside designation,...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of HAVRIX 1,440 unit/mL syringes to support military healthcare programs. The contract, valued at $31,827.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of October 9, 2024 and was awarded on October 8, 2024. This contract is not designated as a set-aside and is...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,667.40 and an ultimate completion date of April 21, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML medical supplies. The contract has a firm fixed price, with a ceiling value of $32,905.70, and a period of performance through June 26, 2025. This award is not a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a delivery order with a firm fixed price of $7,735.95 and a completion date of September 11, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,833.70, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...